These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 32204575)

  • 21.
    Coan M; Toso M; Cesaratto L; Rigo I; Borgna S; Dalla Pietà A; Zandonà L; Iuri L; Zucchetto A; Piazza C; Baldassarre G; Spizzo R; Nicoloso MS
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762037
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical significance of the interaction between non-coding RNAs and the epigenetics machinery: challenges and opportunities in oncology.
    Maia BM; Rocha RM; Calin GA
    Epigenetics; 2014 Jan; 9(1):75-80. PubMed ID: 24121593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
    Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
    Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long non-coding RNAs and their relevance in cancer].
    Sána J; Faltejsková P; Svoboda M; Slabý O
    Klin Onkol; 2012; 25(4):246-54. PubMed ID: 22920164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-coding RNAs derailed: The many influences on the fatty acid reprogramming of cancer.
    Yu XH; Wang HF; Wu JB; Wang SS; Tang YJ; Tang YL; Liang XH
    Life Sci; 2019 Aug; 231():116509. PubMed ID: 31152812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance.
    Lampropoulou DI; Pliakou E; Aravantinos G; Filippou D; Gazouli M
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Non-coding RNAs, epigenetics, and cancer: tying it all together.
    Ferreira HJ; Esteller M
    Cancer Metastasis Rev; 2018 Mar; 37(1):55-73. PubMed ID: 29374363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single-Cell Non-coding RNA in Embryonic Development.
    Fu Q; Liu CJ; Zhai ZS; Zhang X; Qin T; Zhang HW
    Adv Exp Med Biol; 2018; 1068():19-32. PubMed ID: 29943293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance.
    Shi T; Zhang C; Xia S
    Mol Cell Biochem; 2022 May; 477(5):1371-1380. PubMed ID: 35142950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are Non-Coding RNAs Useful Biomarkers in Parathyroid Tumorigenesis?
    Aurilia C; Donati S; Palmini G; Miglietta F; Falsetti I; Iantomasi T; Brandi ML
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
    Fanale D; Barraco N; Listì A; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The p53 family reaches the final frontier: the variegated regulation of the dark matter of the genome by the p53 family in cancer.
    Napoli M; Flores ER
    RNA Biol; 2020 Nov; 17(11):1636-1647. PubMed ID: 31910062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-coding RNAs for medical practice in oncology.
    Setoyama T; Ling H; Natsugoe S; Calin GA
    Keio J Med; 2011; 60(4):106-13. PubMed ID: 22200634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual Effects of Non-Coding RNAs (ncRNAs) in Cancer Stem Cell Biology.
    Kyriazi AA; Papiris E; Kitsos Kalyvianakis K; Sakellaris G; Baritaki S
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter".
    Grillone K; Riillo C; Scionti F; Rocca R; Tradigo G; Guzzi PH; Alcaro S; Di Martino MT; Tagliaferri P; Tassone P
    J Exp Clin Cancer Res; 2020 Jun; 39(1):117. PubMed ID: 32563270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A transcriptomic profile of topping responsive non-coding RNAs in tobacco roots (Nicotiana tabacum).
    Chen X; Sun S; Liu F; Shen E; Liu L; Ye C; Xiao B; Timko MP; Zhu QH; Fan L; Cao P
    BMC Genomics; 2019 Nov; 20(1):856. PubMed ID: 31726968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNAs in Cancer.
    Lux S; Bullinger L
    Adv Exp Med Biol; 2018; 1087():215-230. PubMed ID: 30259369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gynecologic cancers and non-coding RNAs: Epigenetic regulators with emerging roles.
    Razavi ZS; Tajiknia V; Majidi S; Ghandali M; Mirzaei HR; Rahimian N; Hamblin MR; Mirzaei H
    Crit Rev Oncol Hematol; 2021 Jan; 157():103192. PubMed ID: 33290823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of F-box proteins by noncoding RNAs in human cancers.
    Lin M; Xu Y; Gao Y; Pan C; Zhu X; Wang ZW
    Cancer Lett; 2019 Dec; 466():61-70. PubMed ID: 31546023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.